Description
FR 167653 free base is an orally active p38 MAPK inhibitor and is effective in treating inflammation, relieving truMa, and ischemia-reperfusion injury in vivo. It also is a potent suppressor of TNF-alpha and IL-1beta production via specific inhibition of p38 MAPK activity